Product Information

PRADAXA 75 MG CAPSULE is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $3.1584 per EA under NDC 00597035509. Its NADAC has been published 441 times since Mar 14, 2018.

FDA first approved this application on Oct 19, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRADAXA 75 MG CAPSULE

dabigatran etexilate mesylate
$3.1584per EA

Strength

75 mg/1

NDC

00597035509

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA022512

FDA Approved

10/19/2010

TE Code

AB

On Market Since

8/8/2011

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price Statistics

The NADAC for PRADAXA 75 MG CAPSULE has been published 441 times since Mar 14, 2018, and over the history we have for it it has declined 50.8%. The table below summarizes its recorded NADAC range and movement.

Current price$3.1584 per EA
All-time high$7.9382 (Jun 28, 2023)
All-time low$3.1576 (Jul 22, 2026)
52-week high$3.1679
52-week low$3.1576
Median price$6.9000
Average price$5.7823
Largest weekly change-60.0% (Jul 5, 2023)
Weeks tracked441
Tracking sinceMar 14, 2018

Price History

1W

+0.0%

1M

+0.0%

3M

-0.1%

6M

-0.2%

1Y

-0.2%

3Y

-0.5%

5Y

-58.7%

All

-50.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PRADAXA 75 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PRADAXA 75 MG CAPSULE, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $3.1584 per EA (NDC 00597035509), effective Aug 19, 2026.

How has the price of PRADAXA 75 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PRADAXA 75 MG CAPSULE has declined 50.8%. It has been tracked across 441 weekly CMS publications since Mar 14, 2018.

What are the highest and lowest recorded NADAC prices for PRADAXA 75 MG CAPSULE?

Since Mar 14, 2018, the NADAC for PRADAXA 75 MG CAPSULE has ranged from a low of $3.1576 (Jul 22, 2026) to a high of $7.9382 (Jun 28, 2023), with a median of $6.9000 per EA.

Are there cheaper alternatives to PRADAXA 75 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PRADAXA 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures PRADAXA 75 MG CAPSULE?

PRADAXA 75 MG CAPSULE (NDC 00597035509) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.